{"entity":{"type":"insider","cik":"0001529655","url":"/insider/0001529655","json_url":"/insider/0001529655.json","name":"Robb Gary Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":25,"first":"2017-05-08","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Robb Gary Charles","source":"filing","n_filings":25,"first_seen":"2017-05-08","last_seen":"2026-08-18"}],"transactions":[{"id":9255874,"accession":"0001193125-26-355560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-355560","line_url":"/filing/0001193125-26-355560#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":116.2572,"price_display":"116.26","price_state":"stated","total_value":1162572.0,"total_display":"1,162,572.00","total_whole":"1,162,572","shares_owned_after":39716.0,"shares_owned_after_display":"39,716","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":4845084,"accession":"0001193125-25-188869","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-188869","line_url":"/filing/0001193125-25-188869#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2326.0,"shares_display":"2,326","price_per_share":71.27,"price_display":"71.27","price_state":"stated","total_value":165774.02,"total_display":"165,774.02","total_whole":"165,774","shares_owned_after":16038.0,"shares_owned_after_display":"16,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4313584,"accession":"0000950170-25-088005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088005","line_url":"/filing/0000950170-25-088005#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3185.0,"shares_display":"3,185","price_per_share":70.77,"price_display":"70.77","price_state":"stated","total_value":225402.45,"total_display":"225,402.45","total_whole":"225,402","shares_owned_after":13364.0,"shares_owned_after_display":"13,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":4132290,"accession":"0000950170-25-076417","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-076417","line_url":"/filing/0000950170-25-076417#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2279.0,"shares_display":"2,279","price_per_share":75.85,"price_display":"75.85","price_state":"stated","total_value":172862.15,"total_display":"172,862.15","total_whole":"172,862","shares_owned_after":16586.0,"shares_owned_after_display":"16,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":5195904,"accession":"0000950170-25-002439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002439","line_url":"/filing/0000950170-25-002439#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":50.5047,"price_display":"50.50","price_state":"stated","total_value":555551.7,"total_display":"555,551.70","total_whole":"555,552","shares_owned_after":20119.0,"shares_owned_after_display":"20,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2243214,"accession":"0000950170-24-131176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-131176","line_url":"/filing/0000950170-24-131176#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2609.0,"shares_display":"2,609","price_per_share":56.2,"price_display":"56.20","price_state":"stated","total_value":146625.8,"total_display":"146,625.80","total_whole":"146,626","shares_owned_after":20163.0,"shares_owned_after_display":"20,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"},{"id":2393990,"accession":"0000950170-24-111052","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-111052","line_url":"/filing/0000950170-24-111052#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":46.28,"price_display":"46.28","price_state":"stated","total_value":509080.0,"total_display":"509,080.00","total_whole":"509,080","shares_owned_after":22772.0,"shares_owned_after_display":"22,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-01","scope":"insider"},{"id":2772235,"accession":"0000950170-24-101501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-101501","line_url":"/filing/0000950170-24-101501#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3101.0,"shares_display":"3,101","price_per_share":35.71,"price_display":"35.71","price_state":"stated","total_value":110736.71,"total_display":"110,736.71","total_whole":"110,737","shares_owned_after":23190.0,"shares_owned_after_display":"23,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2589170,"accession":"0000950170-24-081594","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081594","line_url":"/filing/0000950170-24-081594#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":32.49,"price_display":"32.49","price_state":"stated","total_value":357390.0,"total_display":"357,390.00","total_whole":"357,390","shares_owned_after":26291.0,"shares_owned_after_display":"26,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":3020721,"accession":"0000950170-24-066889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066889","line_url":"/filing/0000950170-24-066889#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":30.3904,"price_display":"30.39","price_state":"stated","total_value":334294.4,"total_display":"334,294.40","total_whole":"334,294","shares_owned_after":20203.0,"shares_owned_after_display":"20,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":7801414,"accession":"0000950170-23-068650","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-068650","line_url":"/filing/0000950170-23-068650#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6212.0,"shares_display":"6,212","price_per_share":27.01,"price_display":"27.01","price_state":"stated","total_value":167786.12,"total_display":"167,786.12","total_whole":"167,786","shares_owned_after":21390.0,"shares_owned_after_display":"21,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-06","scope":"insider"},{"id":7801412,"accession":"0000950170-23-068650","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-068650","line_url":"/filing/0000950170-23-068650#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1381.0,"shares_display":"1,381","price_per_share":26.2688,"price_display":"26.27","price_state":"stated","total_value":36277.2128,"total_display":"36,277.21","total_whole":"36,277","shares_owned_after":27602.0,"shares_owned_after_display":"27,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":7838523,"accession":"0000950170-23-049039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-049039","line_url":"/filing/0000950170-23-049039#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.7354,"price_display":"32.74","price_state":"stated","total_value":163677.0,"total_display":"163,677.00","total_whole":"163,677","shares_owned_after":21996.0,"shares_owned_after_display":"21,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-20","scope":"insider"},{"id":7961936,"accession":"0000899243-23-012758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-012758","line_url":"/filing/0000899243-23-012758#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":24.07,"price_display":"24.07","price_state":"stated","total_value":336980.0,"total_display":"336,980.00","total_whole":"336,980","shares_owned_after":19997.0,"shares_owned_after_display":"19,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-11","scope":"insider"},{"id":7961934,"accession":"0000899243-23-012758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-012758","line_url":"/filing/0000899243-23-012758#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":23.87,"price_display":"23.87","price_state":"stated","total_value":716100.0,"total_display":"716,100.00","total_whole":"716,100","shares_owned_after":33997.0,"shares_owned_after_display":"33,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-11","scope":"insider"},{"id":6561349,"accession":"0000899243-22-036970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036970","line_url":"/filing/0000899243-22-036970#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186.0,"shares_display":"186","price_per_share":26.03,"price_display":"26.03","price_state":"stated","total_value":4841.58,"total_display":"4,841.58","total_whole":"4,842","shares_owned_after":21143.0,"shares_owned_after_display":"21,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-23","scope":"insider"},{"id":6561344,"accession":"0000899243-22-036970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036970","line_url":"/filing/0000899243-22-036970#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4814.0,"shares_display":"4,814","price_per_share":26.03,"price_display":"26.03","price_state":"stated","total_value":125308.42,"total_display":"125,308.42","total_whole":"125,308","shares_owned_after":21329.0,"shares_owned_after_display":"21,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6386670,"accession":"0000899243-22-036534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036534","line_url":"/filing/0000899243-22-036534#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13401.0,"shares_display":"13,401","price_per_share":26.43,"price_display":"26.43","price_state":"stated","total_value":354188.43,"total_display":"354,188.43","total_whole":"354,188","shares_owned_after":26143.0,"shares_owned_after_display":"26,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":6386667,"accession":"0000899243-22-036534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036534","line_url":"/filing/0000899243-22-036534#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.06,"price_display":"26.06","price_state":"stated","total_value":260600.0,"total_display":"260,600.00","total_whole":"260,600","shares_owned_after":39544.0,"shares_owned_after_display":"39,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":6620636,"accession":"0000899243-22-030683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030683","line_url":"/filing/0000899243-22-030683#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":26.06,"price_display":"26.06","price_state":"stated","total_value":1303000.0,"total_display":"1,303,000.00","total_whole":"1,303,000","shares_owned_after":49544.0,"shares_owned_after_display":"49,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-08","scope":"insider"},{"id":6472014,"accession":"0000899243-22-025826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-025826","line_url":"/filing/0000899243-22-025826#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":1170000.0,"total_display":"1,170,000.00","total_whole":"1,170,000","shares_owned_after":24123.0,"shares_owned_after_display":"24,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-08","scope":"insider"},{"id":6803735,"accession":"0000899243-22-018862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-018862","line_url":"/filing/0000899243-22-018862#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6127.0,"shares_display":"6,127","price_per_share":19.5737,"price_display":"19.57","price_state":"stated","total_value":119928.0599,"total_display":"119,928.06","total_whole":"119,928","shares_owned_after":36446.0,"shares_owned_after_display":"36,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider"},{"id":6803732,"accession":"0000899243-22-018862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018862","line_url":"/filing/0000899243-22-018862#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128.0,"shares_display":"128","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":2502.4,"total_display":"2,502.40","total_whole":"2,502","shares_owned_after":42573.0,"shares_owned_after_display":"42,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6803727,"accession":"0000899243-22-018862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018862","line_url":"/filing/0000899243-22-018862#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28745.0,"shares_display":"28,745","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":561964.75,"total_display":"561,964.75","total_whole":"561,965","shares_owned_after":42701.0,"shares_owned_after_display":"42,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6139483,"accession":"0000899243-22-011614","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011614","line_url":"/filing/0000899243-22-011614#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4988.0,"shares_display":"4,988","price_per_share":24.67,"price_display":"24.67","price_state":"stated","total_value":123053.96,"total_display":"123,053.96","total_whole":"123,054","shares_owned_after":71446.0,"shares_owned_after_display":"71,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-18","scope":"insider"},{"id":6139480,"accession":"0000899243-22-011614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011614","line_url":"/filing/0000899243-22-011614#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7512.0,"shares_display":"7,512","price_per_share":24.6771,"price_display":"24.68","price_state":"stated","total_value":185374.3752,"total_display":"185,374.38","total_whole":"185,374","shares_owned_after":76434.0,"shares_owned_after_display":"76,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-18","scope":"insider"},{"id":4267505,"accession":"0000899243-21-036139","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036139","line_url":"/filing/0000899243-21-036139#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47853.0,"shares_display":"47,853","price_per_share":20.4949,"price_display":"20.49","price_state":"stated","total_value":980742.4497,"total_display":"980,742.45","total_whole":"980,742","shares_owned_after":87848.0,"shares_owned_after_display":"87,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-15","scope":"insider"},{"id":4267500,"accession":"0000899243-21-036139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-036139","line_url":"/filing/0000899243-21-036139#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":806.0,"shares_display":"806","price_per_share":20.7639,"price_display":"20.76","price_state":"stated","total_value":16735.7034,"total_display":"16,735.70","total_whole":"16,736","shares_owned_after":135701.0,"shares_owned_after_display":"135,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":4267494,"accession":"0000899243-21-036139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-036139","line_url":"/filing/0000899243-21-036139#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6341.0,"shares_display":"6,341","price_per_share":20.8871,"price_display":"20.89","price_state":"stated","total_value":132445.1011,"total_display":"132,445.10","total_whole":"132,445","shares_owned_after":136507.0,"shares_owned_after_display":"136,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4404828,"accession":"0000899243-21-017125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-017125","line_url":"/filing/0000899243-21-017125#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.0219,"price_display":"24.02","price_state":"stated","total_value":240219.0,"total_display":"240,219.00","total_whole":"240,219","shares_owned_after":75638.0,"shares_owned_after_display":"75,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-27","scope":"insider"},{"id":4450345,"accession":"0000899243-21-006772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-006772","line_url":"/filing/0000899243-21-006772#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112100.0,"shares_display":"112,100","price_per_share":28.2239,"price_display":"28.22","price_state":"stated","total_value":3163899.19,"total_display":"3,163,899.19","total_whole":"3,163,899","shares_owned_after":85638.0,"shares_owned_after_display":"85,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-12","filed_date":"2021-02-16","scope":"insider"},{"id":4450339,"accession":"0000899243-21-006772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-006772","line_url":"/filing/0000899243-21-006772#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":29.7791,"price_display":"29.78","price_state":"stated","total_value":101248.94,"total_display":"101,248.94","total_whole":"101,249","shares_owned_after":197738.0,"shares_owned_after_display":"197,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":7808364,"accession":"0000899243-19-028931","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028931","line_url":"/filing/0000899243-19-028931#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":13.7343,"price_display":"13.73","price_state":"stated","total_value":412029.0,"total_display":"412,029.00","total_whole":"412,029","shares_owned_after":8025.0,"shares_owned_after_display":"8,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":6745349,"accession":"0000899243-18-031129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-031129","line_url":"/filing/0000899243-18-031129#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":19.0061,"price_display":"19.01","price_state":"stated","total_value":475152.5,"total_display":"475,152.50","total_whole":"475,153","shares_owned_after":6858.0,"shares_owned_after_display":"6,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":5051233,"accession":"0000899243-17-012254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-012254","line_url":"/filing/0000899243-17-012254#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001529655","owner_name":"Robb Gary Charles","owner_display_name":"Robb Gary Charles","owner_url":"/insider/0001529655","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5600.0,"shares_display":"5,600","price_per_share":9.7479,"price_display":"9.75","price_state":"stated","total_value":54588.24,"total_display":"54,588.24","total_whole":"54,588","shares_owned_after":6858.0,"shares_owned_after_display":"6,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-04","filed_date":"2017-05-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Officer (Chief Business Officer)","n_filings":25,"first_seen":"2017-05-08","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001529655","retrieved_at":"2026-08-26T05:21:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}